Replies to post #3284 on Skye Bioscience Inc (SKYE)

[GM26]

Nemus will be much bigger than InMed, mark my words, this is big league stuff here and older investors are just Butt hurt about the loses which is understandable it it doesn’t change the fact that Buying now is beneficial to ALL shareholders except for short sellers.

[cjarmstrong]

I haven't owned or followed InMed in a while, but with Emerald running the show I think Nemus can substantially close the valuation gap.